|Day Low/High||0.10 / 0.10|
|52 Wk Low/High||0.04 / 0.79|
Covers composition of matter and method of use for proprietary PDCs™ in combination with anti-cancer agents
Conference call to be held tomorrow at 8:30 a.m. Eastern time
Multiple myeloma cohort exceeded pre-specified criteria for clinically meaningful benefit
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.